Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.26 USD | +5.76% | +3.38% | +64.54% |
Chart calendar ImmunityBio, Inc.
Upcoming events on ImmunityBio, Inc.
Past events on ImmunityBio, Inc.
2024-05-05 11:32 am | American Urological Association Meeting |
2024-05-03 02:00 pm | American Urological Association Meeting |
2024-04-26 11:00 am | ANKTIVA® FDA Approval Call |
2023-11-30 10:30 am | Piper Sandler Healthcare Conference |
2023-11-03 | Society for Immunotherapy of Cancer Meeting - Abstract Number :358 |
2023-11-01 | LUGPA Meeting |
2023-10-31 | Society for Immunotherapy of Cancer Meeting |
2023-07-06 | AACR - AHNS Joint Conference |
2023-06-13 12:30 pm | Annual General Meeting |
2023-06-13 12:30 pm | Annual General Meeting |
2023-06-07 10:00 am | Jefferies Global Healthcare Conference |
2023-06-01 | ASCO Meeting |
2023-04-27 | American Urological Association Meeting - Booth no. 3807 |
2023-03-27 | Hanson Wade Innate Killer Summit |
2023-02-16 02:30 pm | American Society of Clinical Oncology Genitourinary Cancers Symposium - Abstract No: 495 |
2023-01-18 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium |
2022-11-29 02:30 pm | Piper Sandler Healthcare Conference - Fireside Chat |
2022-11-15 11:25 am | Jefferies London Healthcare Conference |
2022-08-07 | Interim 2022 Earnings Release |
2022-06-14 12:30 pm | Annual General Meeting |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,93 0,57 64.15% | 0,24 0,30 -18.92% | 0,62 0,51 22.44% | 71,6 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -330 -331 0.21% | -351 -335 -4.74% | -362 -357 -1.52% | -332 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -350 -341 -2.51% | -417 -398 -4.82% | -584 -474 -23.26% | -439 |
Net income Million USD | Released Forecast Spread | -347 -341 -1.62% | -417 -398 -4.64% | -583 -474 -23.11% | -437 |
EPS USD | Released Forecast Spread | -0,89 -1,35 34.07% | -1,04 -0,94 -10.64% | -1,15 -0,93 -23.66% | -0,75 |
Announcement Date | 01/03/22 | 01/03/23 | 19/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,39 0,03 1460% | 0,01 0,03 -44% | 0,04 | 0,12 0,06 88.8% | 0,07 0,03 192% | 0,36 0,03 1340% | 0,04 0,03 64% | 0,08 0,40 -79.5% | 0,14 0,03 456% | 0,03 | 2,53 | 10,0 | 22,7 | 35,0 |
EBIT Million USD | Released Forecast Spread | -79,3 -80,0 0.88% | -96,0 -80,0 -20% | -90,8 -75,0 -21.11% | -84,9 -75,0 -13.24% | -112 -95,0 -17.48% | -85,1 -100,0 14.83% | -80,1 -73,0 -9.78% | -85,4 -80,0 -6.77% | -87,5 | -90,9 | -85,7 | -78,7 | -68,6 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -91,6 -83,0 -10.33% | -103 -85,7 -20.25% | -111 -86,3 -28.79% | -108 -89,1 -21.55% | -117 -109 -6.5% | -138 -116 -19.62% | -95,6 -80,5 -18.81% | -233 -123 -89.39% | -111 | -115 | -109 | -103 | -93,0 | |
Net income Million USD | Released Forecast Spread | -91,3 -83,0 -9.97% | -103 -85,7 -20.05% | -111 -86,3 -28.53% | -108 -89,1 -21.46% | -116 -109 -6.28% | -138 -116 -19.33% | -95,6 -79,7 -20% | -233 -123 -89.34% | -111 | -115 | -109 | -103 | -93,0 | |
EPS USD | Released Forecast Spread | -0,23 -0,21 -9.52% | -0,26 -0,22 -18.18% | -0,24 -0,24 0% | -0,28 -0,22 -30.23% | -0,27 -0,17 -63.64% | -0,27 -0,27 0% | -0,32 -0,24 -36.17% | -0,19 -0,18 -5.56% | -0,38 -0,18 -111.11% | -0,16 | -0,17 | -0,16 | -0,15 | -0,14 |
Announcement Date | 01/03/22 | 10/05/22 | 08/08/22 | 09/11/22 | 01/03/23 | 11/05/23 | 08/08/23 | 09/11/23 | 19/03/24 | - | - | - | - | - |
Today 04:01 pm | HALOZYME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-07 | ANAPTYSBIO, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-07 | RAPT THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-07 | ALX ONCOLOGY HOLDINGS INC.: Q1 2024 Earnings Release (Projected) |
2024-05-07 | 89BIO, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-07 | DYNAVAX TECHNOLOGIES CORPORATION: Q1 2024 Earnings Release |
2024-05-07 | BEIGENE, LTD.: Q1 2024 Earnings Release |
2024-05-08 04:00 pm | MANNKIND CORPORATION: Q1 2024 Earnings Release |
2024-05-08 04:00 pm | CYTOKINETICS, INCORPORATED: Q1 2024 Earnings Release |
2024-05-08 04:05 pm | PROTHENA CORPORATION PLC: Q1 2024 Earnings Release |
Past sector events for ImmunityBio, Inc.
Today 07:00 am | RHYTHM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Today 07:00 am | MADRIGAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Today | COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
Today | Y-MABS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Today | INNOCARE PHARMA LIMITED: Q1 2024 Earnings Release (Projected) |
Today | PHILOGEN S.P.A.: Q1 2024 Earnings Release |
2024-05-06 04:05 pm | ORIC PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-06 04:01 pm | ROCKET PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-06 04:01 pm | VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
2024-05-06 08:00 am | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IBRX Stock
- Calendar ImmunityBio, Inc.